|
1
|
Marrack P, Kappler J and Kotzin BL:
Autoimmune disease: Why and where it occurs. Nat Med. 7:899–905.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lau CS, Yin G and Mok MY: Ethnic and
geographical differences in systemic lupus erythematosus: An
overview. Lupus. 15:715–719. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Adib-Conquy M, Adrie C, Fitting C,
Gattolliat O, Beyaert R and Cavaillon JM: Up-regulation of MyD88s
and SIGIRR, molecules inhibiting Toll-like receptor signaling, in
monocytes from septic patients. Crit Care Med. 34:2377–2385. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Riva F, Bonavita E, Barbati E, Muzio M,
Mantovani A and Garlanda C: TIR8/SIGIRR is an interleukin-1
receptor/toll like receptor family member with regulatory functions
in inflammation and immunity. Front Immunol. 3:3222012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garlanda C, Riva F, Veliz T, Polentarutti
N, Pasqualini F, Radaelli E, Sironi M, Nebuloni M, Zorini EO,
Scanziani E, et al: Increased susceptibility to colitis-associated
cancer of mice lacking TIR8, an inhibitory member of the
interleukin-1 receptor family. Cancer Res. 67:6017–6021. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sha Y and Markovic-Plese S: A role of
IL-1R1 signaling in the differentiation of Th17 cells and the
development of autoimmune diseases. Self Nonself. 2:35–42. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bettelli E, Carrier Y, Gao W, Korn T,
Strom TB, Oukka M, Weiner HL and Kuchroo VK: Reciprocal
developmental pathways for the generation of pathogenic effector
TH17 and regulatory T cells. Nature. 441:235–238. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang XO, Pappu BP, Nurieva R, Akimzhanov
A, Kang HS, Chung Y, Ma L, Shah B, Panopoulos AD, Schluns KS, et
al: T helper 17 lineage differentiation is programmed by orphan
nuclear receptors ROR alpha and ROR gamma. Immunity. 28:29–39.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dinarello CA: Immunological and
inflammatory functions of the interleukin-1 family. Annu Rev
Immunol. 27:519–550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poissonnier A, Sanséau D, Le Gallo M,
Malleter M, Levoin N, Viel R, Morere L, Penna A, Blanco P, Dupuy A,
et al: CD95-mediated calcium signaling promotes T Helper 17
trafficking to inflamed organs in lupus-prone mice. Immunity.
45:209–223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hammad A, Osman E, Mosaad Y and Wahba M:
Serum interleukin-17 in Egyptian children with systemic lupus
erythematosus: Is it related to pulmonary affection? Lupus.
26:388–395. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu H, Zhen Y, Ma Z, Li H, Yu J, Xu ZG,
Wang XY, Yi H and Yang YG: Arginase-1-dependent promotion of TH17
differentiation and disease progression by MDSCs in systemic lupus
erythematosus. Sci Transl Med. 8:331ra402016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sigdel KR, Duan L, Wang Y, Hu W, Wang N,
Sun Q, Liu Q, Liu X, Hou X, Cheng A, et al: Serum Cytokines Th1,
Th2, and Th17 expression profiling in active lupus nephritis-IV:
From a Southern Chinese Han Population. Mediators Inflamm.
2016:49275302016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin J, Qian Y, Yao J, Grace C and Li X:
SIGIRR inhibits interleukin-1 receptor- and toll-like receptor
4-mediated signaling through different mechanisms. J Biol Chem.
280:25233–25241. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lech M, Kulkarni OP, Pfeiffer S, Savarese
E, Krug A, Garlanda C, Mantovani A and Anders HJ: Tir8/Sigirr
prevents murine lupus by suppressing the immunostimulatory effects
of lupus autoantigens. J Exp Med. 205:1879–1888. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Datta SK, Zhang L and Xu L: T-helper cell
intrinsic defects in lupus that break peripheral tolerance to
nuclear autoantigens. J Mol Med (Berl). 83:267–278. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stahl M, Ries J, Vermeulen J, Yang H, Sham
HP, Crowley SM, Badayeva Y, Turvey SE, Gaynor EC, Li X, et al: A
novel mouse model of Campylobacter jejuni gastroenteritis
reveals key pro-inflammatory and tissue protective roles for
Toll-like receptor signaling during infection. PLoS Pathog.
10:e10042642014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan EM, Cohen AS, Fries JF, Masi AT,
McShane DJ, Rothfield NF, Schaller JG, Talal N and Winchester RJ:
The 1982 revised criteria for the classification of systemic lupus
erythematosus. Arthritis Rheum. 25:1271–1277. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bombardier C, Gladman DD, Urowitz MB,
Caron D, Chang CH, Austin A, Bell A, Bloch DA, Corey PN, Decker JL,
et al: The Committee on Prognosis Studies in SLE: Derivation of the
SLEDAI. A disease activity index for lupus patients. Arthritis
Rheum. 35:630–640. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang DY, Su C, Chen GM, Pan HF, Wang FM,
Liu GL, Hao L, Wang DG and Ye DQ: The decreased frequency of
SIGIRR-positive CD4+ T cells in peripheral blood of
patients with SLE and its correlation with disease activity. Mol
Biol Rep. 42:423–430. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang C, Wu X, Zhao Y, Deng Z and Qian G:
SIGIRR inhibits toll-like receptor 4, 5, 9-mediated immune
responses in human airway epithelial cells. Mol Biol Rep.
38:601–609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang J, Chu Y, Yang X, Gao D, Zhu L, Yang
X, Wan L and Li M: Th17 and natural Treg cell population dynamics
in systemic lupus erythematosus. Arthritis Rheum. 60:1472–1483.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Garlanda C, Anders HJ and Mantovani A:
TIR8/SIGIRR: An IL-1R/TLR family member with regulatory functions
in inflammation and T cell polarization. Trends Immunol.
30:439–446. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao H, Gulen MF, Qin J, Yao J, Bulek K,
Kish D, Altuntas CZ, Wald D, Ma C, Zhou H, et al: The
Toll-interleukin-1 receptor member SIGIRR regulates colonic
epithelial homeostasis, inflammation, and tumorigenesis. Immunity.
26:461–475. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao XF, Pan HF, Yuan H, Zhang WH, Li XP,
Wang GH, Wu GC, Su H, Pan FM, Li WX, et al: Increased serum
interleukin 17 in patients with systemic lupus erythematosus. Mol
Biol Rep. 37:81–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen DY, Chen YM, Wen MC, Hsieh TY, Hung
WT and Lan JL: The potential role of Th17 cells and Th17-related
cytokines in the pathogenesis of lupus nephritis. Lupus.
21:1385–1396. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang C, Feng CC, Pan HF, Wang DG and Ye
DQ: Therapeutic potential of SIGIRR in systemic lupus
erythematosus. Rheumatol Int. 33:1917–1921. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lech M, Garlanda C, Mantovani A,
Kirschning CJ, Schlöndorff D and Anders HJ: Different roles of
TiR8/Sigirr on Τoll-like receptor signaling in intrarenal
antigen-presenting cells and tubular epithelial cells. Kidney Int.
72:182–192. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu YY, Su Y, Li ZG and Zhang Y: The
largely normal response to Toll-like receptor 7 and 9 stimulation
and the enhanced expression of SIGIRR by B cells in systemic lupus
erythematosus. PLoS One. 7:e441312012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu Y, Wang DG, Yang XK, Tao SS, Huang Q,
Pan HF, Feng CC and Ye DQ: Emerging role of SIGIRR rs7396562(T/G)
polymorphism in systemic lupus erythematosus in a Chinese
population. Inflammation. 37:1847–1851. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gulen MF, Kang Z, Bulek K, Youzhong W, Kim
TW, Chen Y, Altuntas CZ, Sass Bak-Jensen K, McGeachy MJ, Do JS, et
al: The receptor SIGIRR suppresses Th17 cell proliferation via
inhibition of the interleukin-1 receptor pathway and mTOR kinase
activation. Immunity. 32:54–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
